Oxford nanopore sequencing-based assay for BTD gene screening: Design, clinical validation, and variant frequency assessment in the Turkish population
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Istanbul University Scientific Research Projects Unit
This publication has 34 references indexed in Scilit:
- A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseasesThe American Journal of Human Genetics, 2022
- Assessment of two‐pool multiplex long‐amplicon nanopore sequencing of SARS‐CoV‐2Journal of Medical Virology, 2021
- Long‐read nanopore sequencing resolves a TMEM231 gene conversion event causing Meckel–Gruber syndromeHuman Mutation, 2019
- Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinIONMolecular Genetics & Genomic Medicine, 2019
- Accurate Typing of Human Leukocyte Antigen Class I Genes by Oxford Nanopore SequencingThe Journal of Molecular Diagnostics, 2018
- Next generation sequencing as a follow-up test in an expanded newborn screening programmeClinical Biochemistry, 2018
- Detection of biotinidase gene mutations in Turkish patients ascertained by newborn and family screeningEuropean Journal of Pediatrics, 2015
- Asymptomatic adults and older siblings with biotinidase deficiency ascertained by family studies of index casesJournal of Inherited Metabolic Disease, 2005
- Partial biotinidase deficiency is usually due to the D444H mutation in the biotinidase geneHuman Genetics, 1998
- Double mutation (A171T) and (D444H) is a common cause of profound biotinidase deficiency in children ascertained by newborn screening in the United StatesHuman Mutation, 1998